Holoeyes' New CIO
2025-06-24 00:49:59

Holoeyes Appoints First Chief Innovation Officer to Drive Medical Advancements

Holoeyes Introduces Chief Innovation Officer



Holoeyes Inc., renowned for its medical imaging software Holoeyes MD, has recently announced a significant structural change by establishing the position of Chief Innovation Officer (CIO). This move comes as part of the company’s strategy to enhance its growth and innovation in the medical field. Go Hosoki, who also serves as the Director of Business Promotion, has been appointed as the inaugural CIO.

This initiative aligns with the launch of Holoeyes Biz, the company’s enterprise brand, aimed at strengthening collaborations across various sectors, including pharmaceuticals, medical devices, insurance, and education. The establishment of the CIO role signifies Holoeyes' commitment to transition from merely being a technology provider to becoming an active promoter of societal implementations.

Focus Areas of the New CIO



As the CIO, Hosoki will focus on leveraging Holoeyes' technological assets and external partnerships to drive business expansion aimed at real-world applications. The primary focus areas include:

1. Commercialization of Domestic Medical Device Business: Strengthening market deployment of Holoeyes MD and related products by enhancing support for implementation and sales strategies. The goal is to create successful experiences for customers.

2. Expansion of Enterprise Business (Holoeyes Biz): Encouraging the introduction of XR solutions that revolutionize medical communication through partnerships with pharmaceutical companies and medical device manufacturers. This includes sales support, employee training, and educational outreach targeting healthcare professionals.

3. Promoting International Expansion: Focusing on strategic advancements primarily in the Middle East by collaborating with local partners, participating in exhibitions, and undertaking projects to enhance Holoeyes' visibility and establish a foundation for business development in that market.

Comments from Newly Appointed CIO Go Hosoki



On his new appointment as Chief Innovation Officer, Hosoki stated, “As the CIO, I am committed to addressing the challenges and needs within the medical field, ensuring our initiatives lead to practical societal implementations. My mission is to foster a culture of innovation and create value by collaborating with diverse partners. I aim to maintain a flexible perspective that breaks traditional thinking, continuously connecting people, technology, and ideas in our quests.”

Comments from CEO Maki Sugimoto



CEO Maki Sugimoto highlighted that Holoeyes has aimed to bring innovation to the healthcare space through spatial computing technology. The establishment of the CIO role represents a crucial step toward broadening their capabilities and expanding collaborations with various industries, including pharmaceuticals, medical devices, insurance, and education.

Sugimoto remarked, “With the introduction of Holoeyes Biz, we are now positioned to propose new forms of medical communication using XR technology, complementing our medical professionals' solutions. We are eager to enhance our international presence, especially in the Middle East, to deliver Holoeyes' value globally.” The company sees itself as a bridge that connects technology and practice, contributing to the future of healthcare.

About Holoeyes



Founded in October 2016, Holoeyes' mission is to reproduce and share medical images and insights spatially to optimize healthcare. The company has developed VR applications and provided data services tailored for clinical training and education. Its flagship product, Holoeyes MD, was certified as a medical device in February 2020 and has since demonstrated clinical effectiveness across numerous healthcare facilities, currently utilized in about 200 medical departments, including by general surgeons and dentists, both in Japan and internationally.

Company Details:
  • - Name: Holoeyes Inc.
  • - Location: Minato-ku, Tokyo, Japan
  • - Establishment Date: October 2016
  • - CEO: Maki Sugimoto
  • - Capital: 214,375,000 Japanese Yen
  • - Business Focus: Development and sales of medical imaging processing software
  • - Website: holoeyes.jp




画像1

画像2

画像3

Topics Health)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.